Tag: FDA

FDA: Recall of Pharmacist Choice Alcohol Prep Pads

  Editor's Note The Food and Drug Administration (FDA) on December 5 announced the recall of 3 lots of Pharmacist Choice Alcohol Prep Pads by Simple Diagnostics (Coral Springs, Florida), which were manufactured by Foshan Flying Medical Products Co Ltd, located in China. The alcohol pads were recalled because of…

Read More

By: Judy Mathias
December 6, 2017
Share

FDA approves first implanted lens that can be adjusted after cataract surgery

  Editor's Note The Food and Drug Administration (FDA) on November 22 announced the approval of RxSight Inc’s (Pasadena, California) Light Adjustable Lens and Light Delivery Device. This is the first system that allows ophthalmologists to make small adjustments to the implanted lens’ power after cataract surgery to improve visual…

Read More

By: Judy Mathias
November 27, 2017
Share

CMS: Two inpatients needed for hospital survey, resurvey

Editor's Note The Centers for Medicare & Medicaid Services (CMS) has issued a new requirement, effective immediately, that a hospital must have at least two active inpatients at the time of survey, or the survey/resurvey will not be allowed to continue, the Joint Commission reported November 15. The new requirement…

Read More

By: Judy Mathias
November 16, 2017
Share

FDA: Baxter recalls one lot of injectable amiodarone

Editor's Note The Food and Drug Administration (FDA) on November 15 announced the recall by Baxter International (Deerfield, Illinois) of one lot of Nexterone (amiodarone HCL) 150 mg/100 mL premixed injection because of the presence of particulate matter. The particulate matter was identified as polyethylene, the primary constituent of the…

Read More

By: Judy Mathias
November 16, 2017
Share

FDA clears new, faster CBC test

Editor's Note The Food and Drug Administration (FDA) on November 6 cleared a new complete blood cell count (CBC) test that can be run in more healthcare settings and offers faster results for patients and providers. The FDA granted premarket clearance and a Clinical Laboratory Improvement Amendments of 1988 (CLIA)…

Read More

By: Judy Mathias
November 10, 2017
Share

FDA: Safety Alert for Cardinal Health’s Infant/Child Reduced Energy Defibrillation Electrodes

Editor's Note The Food and Drug Administration (FDA) on November 6 issued a Safety Alert saying that Physio-Control (Redmond, Washington) launched a voluntary field action for specific lots of Infant/Child Reduced Energy Defibrillation Electrodes manufactured by Cardinal Health (Dublin, Ohio). There is an issue with the artwork on the electrodes…

Read More

By: Judy Mathias
November 8, 2017
Share

FDA: Recall of prefilled syringes labeled Midazolam that are actually Ondansetron

Editor's Note The FDA announced on November 3 that Fresenius Kabi USA (Lake Zurick, Illinois) is recalling one lot of Midazolam Injection, USP, 2 mg/2 mL packaged in 2 mL prefilled single-use glass syringes because the packages labeled as Midazolam actually contain syringes that are filled with and labeled as…

Read More

By: Judy Mathias
November 7, 2017
Share

FDA: Increased rate of major adverse events with Absorb GT1 Bioresorbable Vascular Scaffold

Editor's Note The Food and Drug Administration (FDA) on October 31 issued a Safety Alert saying that interim study results continue to show an increased rate of major adverse cardiac events and Bioresorbable Vascular Scaffold (BVS) thrombosis in patients receiving the Absorb GT1 BVS by Abbott Vascular (Abbott Park, Illinois),…

Read More

By: Judy Mathias
October 31, 2017
Share

FDA: SCA pharmaceuticals recalls certain lots of injectable products

Editor's Note The Food and Drug Administration (FDA) on October 21 announced the recall by SCA Pharmaceuticals (Little Rock, Arkansas) of various lots of injectable products.  The recall was initiated because of the potential for the products to contain microbial contamination.  Many of the recalled products are used in anesthesia,…

Read More

By: Judy Mathias
October 24, 2017
Share

FDA updates Safety Alert for St Jude defibrillators

Editor's Note The Food and Drug Administration (FDA) on October 19 issued an updated Safety Alert for implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators by St Jude Medical. Because batteries for the devices may fail earlier than expected, St Jude has made available a new battery performance management tool,…

Read More

By: Judy Mathias
October 23, 2017
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat